Zdrowie i gospodarka · 19/12/2014

FDA to Host Public Meeting on Patient-Focused Drug Development for Breast Cancer

The FDA is seeking public input on patient-focused drug development for breast cancer, as part of its performance commitments under the Prescription Drug User Fee Act (PDUFA V). The agency will hold a public meeting to gather patient perspectives on breast cancer treatment approaches.